Trial
NCT01372202
CHFR Methylation Status Esophageal Cancer Study
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
National Cancer Institute (NCI)
Condition
Esophageal Cancer
Intervention
Paclitaxel
Why stopped
Study stopped due to early stopping rule
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-25